Stem Cells for COPD

(SORT-COPD II Trial)

CC
Overseen ByChief Clinical Officer
Age: 18+
Sex: Any
Trial Phase: Phase 1 & 2
Sponsor: SMSbiotech
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is a phase 1b/2a, open-label, non-randomized, observation of 125 adults, with moderate to severe chronic obstructive pulmonary disease, treated with SORT-COPD (SMS cells).

The primary objective of this study is to evaluate the preliminary within-participant changes of SORT-COPD (SMS cells), in suspension, delivered to the lung as an aerosolized mist via a vibrating mesh nebulizer, on respiratory health status in participants with moderate to severe chronic obstructive pulmonary disease.

Who Is on the Research Team?

TS

Trishul Siddharthan, Medical Doctor

Principal Investigator

University of Miami

Are You a Good Fit for This Trial?

This trial is for adults with moderate to severe chronic obstructive pulmonary disease (COPD). Participants should have a confirmed diagnosis of COPD and be able to receive treatment through inhalation. People with other serious health issues or certain lung conditions may not be eligible.

Inclusion Criteria

I agree not to donate semen and will use birth control or abstain during and after the study.
I am 18 years old or older.
I am not pregnant or breastfeeding and use birth control if I can become pregnant.
See 7 more

Exclusion Criteria

My high blood pressure is not controlled or needs more than two medications.
I have a history of heart or blood vessel disease or stroke.
I am not able or willing to follow the study's schedule or procedures.
See 17 more

What Are the Treatments Tested in This Trial?

Interventions

  • SORT-COPD (SMS cells)

Trial Overview

The study is testing the safety and effects of small mobile stem cells (SMS) delivered as an inhaled mist using a nebulizer in people with moderate to severe COPD. All participants will receive the stem cell treatment; there is no placebo group.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Safety Cohort (Phase 1b)Experimental Treatment1 Intervention
Group II: Expansion Cohort (Phase 2a)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

SMSbiotech

Lead Sponsor